Skip to main content
. 2023 May 1;46(6):1271–1281. doi: 10.2337/dc22-2331

Table 1.

Results of PheWAS for PDE1A rs10171703

Sources Related traits Stage Cohort (reference no.) Population Covariates Total N (case subjects) RAF β ± SE/OR (95% CI) P
T2D Knowledge Portal DBP PheWAS UK Biobank and ICBP BP GWAS (29) Europeans Sex, age, age2, BMI, and other study-specific covariates 757,601 0.506 0.130 ± 0.017 4.1 × 10−14
SBP BP-related traits UK Biobank and ICBP BP GWAS (29) Europeans Sex, age, age2, BMI, and other study-specific covariates 738,170 0.505 0.098 ± 0.030 1.1 × 10−3
HT BP-related traits Heart rate and hypertension GWAS (with data from UK Biobank) (37) Europeans 458,554 (144,793) 0.512 1.01(1.01–1.02) 2.9 × 10−4
Body height PheWAS GIANT UK Biobank GWAS (38) Europeans Age, sex, recruitment center, genotyping batches, and PCs 709,342 0.502 −0.008 ± 0.001 4.2 × 10−9
PhenoScanner TPM PheWAS UK Biobank (39,40) Europeans 330,995 −0.009 ± 0.002 2.3 × 10−9
PhenoScanner TFM PheWAS UK Biobank (39,40) Europeans 331,030 −0.009 ± 0.002 3.5 × 10−9
Open Targets ALM PheWAS UK Biobank (41) Europeans AFM, age, age2, PCs, assessment center, and genotyping array 450,243 0.512 −0.013 ± 0.002 1.2 × 10−11

ORs and 95% CIs were reported according to the CHD-related risk allele (C allele) of PDE1A rs10171703. AFM, apendicular fat mass; ALM, appendicular lean mass; GIANT, Genetic Investigation of ANthropometric Traits; HT, hypertension; RAF, risk allele frequency (C allele); TFM, trunk fat-free mass; TPM, trunk predicted mass.